18.94
-0.2(-1.04%)
Currency In USD
Previous Close | 19.14 |
Open | 19.25 |
Day High | 19.43 |
Day Low | 18.6 |
52-Week High | 672 |
52-Week Low | 6.76 |
Volume | 421,392 |
Average Volume | 1.31M |
Market Cap | 130.27M |
PE | -0.11 |
EPS | -176.6 |
Moving Average 50 Days | 16.96 |
Moving Average 200 Days | 23.28 |
Change | -0.2 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of May 09, 2025 at a share price of $18.94. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.04 as of May 09, 2025 at a share price of $18.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
GlobeNewswire Inc.
Apr 29, 2025 1:05 PM GMT
Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune evasion by tumor cells TNX-1700 is in preclinical development for gastric and colorectal cancers CHATHAM, N.J.,
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
GlobeNewswire Inc.
Apr 24, 2025 11:55 AM GMT
TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa monkeypox virus Durability of TNX-801 vaccination shown by six-month pr
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
GlobeNewswire Inc.
Apr 16, 2025 11:00 AM GMT
CHATHAM, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announc